CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS

Código QR

CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS

The aim of this work was to study some parameters of cellular immunity in patients with multiple sclerosis (MS). The study included 10 patients with relapsing-remitting MS aged 32 to 50 years. Diagnosis was clinically established and confirmed by magnetic resonance imaging. Patients did not receive...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	I. P. Ivanova, D. V. Dyomina, M. N. Davydova, G. V. Seledtsova
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2021
Materias:	cellular immunity t-cells cytokines memory cells multiple sclerosis t-cell vaccine Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/75e1defe83484700bc03ebcff0773f6b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

PHENOTYPIC CHARACTERIZATION AND INTRACELLULAR CYTOKINES OF MEMORY T-CELLS IN MULTIPLE SCLEROSIS PATIENTS AFTER T-CELL VACCINATION
por: I. P. Ivanova, et al.
Publicado: (2012)

CLINICAL AND IMMUNOLOGICAL ASPECTS OF T C ELL-BASED VACCINE THERAPY IN PATIENTS WITH PROGREDIENT MULTIPLE SCLEROSIS
por: G. Seledtsova, et al.
Publicado: (2014)

Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis
por: Rivera,Francisco J, et al.
Publicado: (2012)

CYTOKINES AND HERPESVIRUSES IN CHILDREN WITH MULTIPLE SCLEROSIS
por: G. F. Zheleznikova, et al.
Publicado: (2016)

Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis
por: Tobias Moser, et al.
Publicado: (2021)

Multiple sclerosis international
Publicado: (2010)

OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS
por: E. P. Evdoshenko, et al.
Publicado: (2014)

Results of the study of the immunogenic activity of cell envelopes of Francisella tularensis different subspicies (Report 2)
por: A. V. Korneva, et al.
Publicado: (2015)

T–CELL VACCINE PREPARATION FOR MULTIPLE SCLEROSIS TREATMENT
por: I. P. Ivanova, et al.
Publicado: (2014)

SPECIFIC AND NONSPECIFIC IMMUNOREACTIVITY AT THE EXPERIMENTAL TUMOR PROCESS
por: I. V. Savkin, et al.
Publicado: (2012)

Complex analysis of correlation interrelations between indicators of humoral and cellular immunity in persons vaccinated against plague
por: S. N. Klyueva, et al.
Publicado: (2019)

Real living with multiple sclerosis
Publicado: (1993)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi R, et al.
Publicado: (2021)

Cellular immunology

Inadequate Vaccine Responses in Children With Multiple Sclerosis
por: Jonathan D. Santoro, et al.
Publicado: (2021)

A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells
por: Shroff G
Publicado: (2018)

Multiple sclerosis clinical and laboratory research.

MECHANISMS OF ANTI-PROLIFERATIVE EFFECT PRODUCED BY MESENCHYMAL STEM CELLS IN PATIENTS WITH MULTIPLE SCLEROSIS
por: M. M. Zafranskaya, et al.
Publicado: (2014)

Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria
por: Egle Cekanaviciute, et al.
Publicado: (2018)

T Helper Cells in the Immunopathogenesis of Systemic Sclerosis – Current Trends
por: Krasimirova E., et al.
Publicado: (2017)

MICROBIAL AGENTS AS TRIGGERS OF MULTIPLE SCLEROSIS DEVELOPMENT
por: Yu. Froltsova, et al.
Publicado: (2019)

Mesenchymal stem cells in systemic sclerosis therapy
por: Daniel Witold Dudek, et al.
Publicado: (2020)

Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
por: Sylwia Pietrasik, et al.
Publicado: (2021)

INVESTIGATION OF BLOOD MONONUCLEAR CELLS CYTOKINE-PRODUCTION FUNCTION FROM PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH THE ENDOGENOUS RETROVIRUS HERV-E λ 4-1 CONSERVATIVE REGION SYNTHETIC OLIGOPEPTIDE
por: I. A. Goldina, et al.
Publicado: (2021)

Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio
por: Ratthaporn Boonsuth, et al.
Publicado: (2021)

ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSIS
por: I. V. Nekrasova, et al.
Publicado: (2014)

EFFECT OF TRANSPLANTATION OF IMMUNOCOMPETENT CELLS TREATED WITH CAFFEINE ON THE PARAMETERS OF THE NERVOUS SYSTEM FUNCTIONAL ACTIVITY
por: M. A. Knyazheva, et al.
Publicado: (2012)

EFFECT OF IMMUNOTHERAPY ACTIVATED T-LYMPHOCYTES ON CELLULAR IMMUNITY IN DIFFERENT FORMS OF ATOPIC DERMATITIS
por: N. A. Shestakova, et al.
Publicado: (2012)

Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients
por: Anna Sobuś, et al.
Publicado: (2021)

Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis
por: Tran JQ, et al.
Publicado: (2016)

Immunosenescence and Autoimmunity: Exploiting the T-Cell Receptor Repertoire to Investigate the Impact of Aging on Multiple Sclerosis
por: Roberta Amoriello, et al.
Publicado: (2021)

Intestinal microbiota composition and peripheral blood Th cell subsets in patients with multiple sclerosis
por: I. N. Abdurasulova, et al.
Publicado: (2019)

A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine
por: Ariana R. Tagliaferri, et al.
Publicado: (2021)

EFFECTS OF γс-CYTOKINES (IL-2, IL-7 AND IL-15) UPON IN VITRO MATURATION AND DIFFERENTIATION OF CD4<sup>+</sup>CD45RО<sup>+</sup>/CD8<sup>+</sup>CD45RО<sup>+</sup> T CELLS
por: K. A. Yurova, et al.
Publicado: (2018)

Promising Effects of Vitex Agnus-Castus on Quality of Life and Sexual Function in Premenopausal Relapsing Remitting Multiple Sclerosis Patients
por: Sara Rahgooy, et al.
Publicado: (2020)

Paroxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital
por: Mustafa Makki Muqdad
Publicado: (2021)

EVALUATION OF IMMUNOTOXICITY OF THE THERAPEUTIC DRUG PROLONGED ACTION FOR MULTIPLE SCLEROSIS ON RHESUS MONKEYS
por: A. B. Dzheliya, et al.
Publicado: (2015)

Single-cell transcriptomic profiles reveal changes associated with BCG-induced trained immunity and protective effects in circulating monocytes
por: Lingjia Kong, et al.
Publicado: (2021)

Effect of Multiple Sclerosis and Its Treatments on Male Fertility: Cues for Future Research
por: Claudia Massarotti, et al.
Publicado: (2021)

Two Vaccines for <italic toggle="yes">Staphylococcus aureus</italic> Induce a B-Cell-Mediated Immune Response
por: Christopher D. Dupont, et al.
Publicado: (2018)